AI assistant
Novonesis AS Major Shareholding Notification 2024
3377_mrq_2024-11-27_4cd50a35-f19e-4536-b83b-e36d77deba3a.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Major shareholder announcement
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments.
Per November 25, 2024, BlackRock, Inc. has adjusted its holding of shares to an equivalent of 22,879,950 shares, corresponding to 4.88% (previously 5.01%) of the total share capital attached to shares. The combined total of share capital attached to shares and share capital through financial instruments is 5.05% (previously 5.15%).
November 27, 2024 Company announcement No. 49
Contact information
Tobias Bjorklund +45 3077 8682 [email protected]
Anders Enevoldsen +45 5350 1453 [email protected]
Katrine Spedtsberg Poulsen [email protected]
About Novonesis
Novonesis is a global leading biosolutions company transforming the way we all produce, consume and live. In more than 30 industries our biosolutions are helping companies meet their business needs and the needs of our planet. Our 10,000 people worldwide work closely with our partners and customers to challenge conventional thinking and transform business with biology.
CVR number: 10 00 71 27 – LEI: 529900T6WNZXD2R3JW38
Novozymes A/S, part of Novonesis Group Krogshoejvej 36 2880 Bagsvaerd Denmark
